"NAD+ Nucleosidase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme that catalyzes the hydrolysis of nicotinamide adenine dinucleotide (NAD) to NICOTINAMIDE and ADENOSINE DIPHOSPHATE RIBOSE. Some are extracellular (ectoenzymes).The enzyme from some sources also catalyses the hydrolysis of nicotinamide adenine dinucleotide phosphate (NADP).
| Descriptor ID |
D009244
|
| MeSH Number(s) |
D08.811.277.450.430.400 D08.811.913.400.725.115.660
|
| Concept/Terms |
NAD+ Nucleosidase- NAD+ Nucleosidase
- Nucleosidase, NAD+
- NAD+ Glycohydrolase
- Glycohydrolase, NAD+
- NAD-Glycohydrolase
- NAD Glycohydrolase
- NAD-Glycohydrolases
- NAD Glycohydrolases
- Diphosphopyridine Nucleotidase
- Nucleotidase, Diphosphopyridine
- NAD+ Nucleosidases
- Nucleosidases, NAD+
- Diphosphopyridine Nucleotidases
- Nucleotidases, Diphosphopyridine
- NADases
- DPNase
- NADase
NAD(P) Nucleosidase- NAD(P) Nucleosidase
- NADP Nucleosidase
- Nucleosidase, NADP
- NADP-Glycohydrolase
- NADP Glycohydrolase
|
Below are MeSH descriptors whose meaning is more general than "NAD+ Nucleosidase".
Below are MeSH descriptors whose meaning is more specific than "NAD+ Nucleosidase".
This graph shows the total number of publications written about "NAD+ Nucleosidase" by people in this website by year, and whether "NAD+ Nucleosidase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "NAD+ Nucleosidase" by people in Profiles.
-
Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice. J Clin Invest. 2010 Feb; 120(2):545-58.
-
Comparison of CD8(+) T-cell subsets in HIV-infected rapid progressor children versus non--rapid progressor children. J Allergy Clin Immunol. 2001 Aug; 108(2):258-64.
-
CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood. 2001 Jul 01; 98(1):181-6.